{"id":1799,"date":"2021-06-03T15:04:14","date_gmt":"2021-06-03T19:04:14","guid":{"rendered":"https:\/\/lifescivoice.com\/?p=1799"},"modified":"2021-06-03T15:08:19","modified_gmt":"2021-06-03T19:08:19","slug":"roche-is-the-biggest-rd-spender-investing-23-8-of-its-total-sales","status":"publish","type":"post","link":"https:\/\/lifescivoice.com\/roche-is-the-biggest-rd-spender-investing-23-8-of-its-total-sales\/","title":{"rendered":"Roche is the biggest R&#038;D spender investing 23.8% of its total sales"},"content":{"rendered":"\n<p>Last year, the research and development expenditures have been increased by 11% to $86.3 billion by the 11 top pharmaceutical companies of the world. This is the highest annual increase in the past ten years, as the humongous discovery of innovative therapies for COVID-19 has boosted the investments to new extremes.<\/p>\n\n\n\n<p>Pfizer and AstraZeneca both have experienced a 10% increase in investments, while Abbvie reported a 17% increase. Skyrizi and Rinvoq, the immunology products of the company, are undergoing an extravagant program of indications extension.<\/p>\n\n\n\n<p>Only Sanofi, the leading pharmaceutical company, has seen a drop in revenue last year, as a result of the firm\u2019s new CEO efforts to boost the production. Sanofi is also known for possessing one of the lowest Research &amp; Development budgets among the biggest pharmaceuticals, as well as investing the least percentages of earnings back into its pipeline.<\/p>\n\n\n\n<p>The figures indicated below are taken from the annual report of Evaluate Pharma and do not include special R&amp;D costs. Merck &amp; Co, for example, projected a cost of $13.6 billion for 2020, including the upfront cost for various agreements, and $2.7 billion invested on Veloso. As a result, the figures in this research accurately represent the R&amp;D expenditure of these companies.<\/p>\n\n\n\n<p>Roche is continuing to be the big pharmaceutical top clinical investor, both in terms of overall expenditure and reinvestment. Last year, the Swiss company invested 23.8% of its total medicine revenue ( OTC and prescription) into R&amp;D. The company\u2019s invoice undoubtedly rose as a result of its research for possible pandemic therapies.<\/p>\n\n\n\n<p>Pfizer and Lilly invested a higher percentage of their revenues in R&amp;D. However, Pfizer\u2019s percentage was exalted by the spin-off of its Upjohn division. COVID-19 vaccine sales are expected to reach billions this year and will have the contrary impact.<\/p>\n\n\n\n<p>The merger of Celgene with BMS ( Bristol Myers Squibb) has enhanced the R&amp;D expenditure of the latter. Given that top-line variations have a big impact on the spending percentage, it is noted that the Celgene acquisition didn\u2019t change it significantly for BMS.<\/p>\n\n\n\n<p>While some companies reducing their investments in Covid-19 therapies, it\u2019s possible that the R&amp;D budget may be reduced in 2021.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Last year, the research and development expenditures have been increased by 11% to $86.3 billion by the 11 top pharmaceutical companies of the world.<\/p>\n","protected":false},"author":1,"featured_media":1800,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2,34],"tags":[49,406,99],"class_list":{"0":"post-1799","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-featured","8":"category-research-development","9":"tag-innovation","10":"tag-rd-2","11":"tag-roche"},"_links":{"self":[{"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/posts\/1799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/comments?post=1799"}],"version-history":[{"count":0,"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/posts\/1799\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/media\/1800"}],"wp:attachment":[{"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/media?parent=1799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/categories?post=1799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/tags?post=1799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}